ONtrack Biomedical AG strives towards improving the quality of life of patients by developing in-vitro diagnostic tests for early and non-invasive detection and monitoring of cancer.
ONtrack Biomedical’s first pipeline product, PROBAN, is a urine test to improve prostate cancer diagnosis and, thus, the eligibility criteria for prostate biopsy.
PROBAN aims at reducing the pressure on patients and health systems with better informed decisions for the downstream healthcare choices and decreasing the associated cost burden.
Company Details
- Address
- Wagi Strasse, Schlieren,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Zurich.
- HQ
- Schlieren
Ontrack Biomedical Ag Questions
Ontrack Biomedical Ag's website is http://www.ontrackbiomedical.com/
Ontrack Biomedical Ag's LinkedIn profile is https://ch.linkedin.com/company/ontrackbm
Ontrack Biomedical Ag's industry is
Biotechnology Research
Ontrack Biomedical Ag's top competitors are
Augmedi,
Scandit,
Transheps,
Aiquos,
Cellx Biosolutions,
Apersys Ag,
Tethys Robotics,
Getyourguide,
South Pole,
Climeworks.
Ontrack Biomedical Ag's categories are Biotechnology Research
